Skip to main content
OpenTrials
Completed

NCT Number: NCT02053415

Krill Oil as Supplementation to Healthy Young Adults.

The purpose of this study is to examine whether 4 weeks daily intake of krill oil can change the omega-3 index (content of the long chained fatty acids EPA and DHA in relation to the total fatty acids) in the membrane in red blood cells. We investigate this at two different doses. Furthermore, the purpose of the study is also to examine the effect of the krill oil intake on plasma lipids (triacylglycerol, phospholipids and cholesterol), plasma fatty acid composition, as well as product tolerance in healthy, young individuals.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy

Age range

18 year–36 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Department of Clinical Science, University of Bergen

Bergen, 5020, Norway

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy young adults

Exclusion criteria

  • Disease/illness
  • Not able to swallow supplements in capsule form
  • Not willing to take blood samples

Treatment and study plan

Krill oil low dose

Dietary Supplement

3 capsules krill oil per day

Other names: Rimfrost Sublime krill oil

Krill oil high dose

Dietary Supplement

9 capsules krill oil per day

Other names: Rimfrost Sublime krill oil

Primary outcomes

  1. Fatty acid composition in red blood cells (the membrane)

    Time frame: Day 0 (baseline), and day 28 (end)

    Change in fatty acid composition and omega-3 index (sum of % EPA and DHA)

Secondary outcomes

  1. Fasting plasma lipid status

    Time frame: Day o (baseline), and day 28 (end)

    • Change in triacylglycerol levels.
    • Change in phospholipid levels.
    • Change in cholesterol levels (total, ester, free, HDL, LDL).

  2. Fatty acid composition in plasma.

    Time frame: Day 0 (baseline), and day 28 (end)

    Change in fatty acid composition and omega-3 index (sum of % EPA and DHA).

  3. Fasting glucose and glucose tolerance.

    Time frame: Day 0 (baseline), and day 28 (end)

    Change in fasting glucose and glucose tolerance.

  4. Tolerance of and compliance with intervention

    Time frame: Day 28 (end)

    Questionnaire-based

Sponsors and collaborators

Lead sponsor

University of Bergen

Other

Collaborators

  • Olympic Seafood AS

Registry information

Official study title

Study of the Effect of Krill Oil Supplement on Omega-3 Fatty Acid Index and Tolerance

Important dates

Study start
2014
Primary completion
2014
Study completion
2014
First posted
Feb 3, 2014
Registry last updated
Mar 14, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.